Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide

To investigate anti-modified citrullinated vimentin (anti-MCV) in early rheumatoid arthritis (RA), including correlation with disease activity and cardiovascular risk factors, compared with anti-cyclic citrullinated peptides (anti-CCP3). Anti-MCV and anti-CCP3 concentrations were measured in 100 pat...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of rheumatology Vol. 38; no. 5; pp. 828 - 834
Main Authors:	EL-BARBARY, Amal M, KASSEM, Elham M, EL-SERGANY, Mervat A. S, ESSA, Salwa A-M, ELTOMEY, Mohamed A
Format:	Journal Article
Language:	English
Published:	Toronto, ON Journal of Rheumatology Publishing 01-05-2011
Subjects:	Adult Aged Antibodies, Anti-Idiotypic - blood Apolipoprotein A-I - blood Apolipoproteins B - blood Arthritis, Rheumatoid - immunology Atherosclerosis (general aspects, experimental research) Atherosclerosis - immunology Autoantibodies - blood Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Carotid Artery, Common - diagnostic imaging Citrulline - immunology Diseases of the osteoarticular system Enzyme-Linked Immunosorbent Assay Female Humans Inflammatory joint diseases Male Medical sciences Middle Aged Nephelometry and Turbidimetry Peptides, Cyclic - immunology Risk Factors Sensitivity and Specificity Severity of Illness Index Ultrasonography Vimentin - immunology Vimentin Immunopathology Cyclic peptides Diseases of the osteoarticular system Rheumatology ANTI-CYCLIC CITRULLINATED PEPTIDE Autoimmune disease Cardiovascular disease Inflammatory joint disease Vascular disease ANTI-MODIFIED CITRULLINATED VIMENTIN Chronic Rheumatoid arthritis Atherosclerosis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!